版本:
中国

BRIEF-Summit Therapeutics Plc Q1 loss £4.8 million

June 14 Summit Therapeutics Plc

* Summit Therapeutics reports financial results for the first quarter ended 30 april 2017 and operational progress

* Summit Therapeutics Plc - cash and cash equivalents at 30 april 2017 of £19.4 million compared to £28.1 million at 31 january 2017

* Summit Therapeutics Plc- loss for three months ended 30 april 2017 of £4.8 million compared to a loss of £5.4 million for three months ended 30 april 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐